Mackenzie Financial Corp Sells 10,388 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Mackenzie Financial Corp decreased its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 33.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,455 shares of the health services provider’s stock after selling 10,388 shares during the quarter. Mackenzie Financial Corp’s holdings in Teladoc Health were worth $441,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in TDOC. Arizona State Retirement System lifted its position in Teladoc Health by 1.4% during the third quarter. Arizona State Retirement System now owns 46,602 shares of the health services provider’s stock worth $866,000 after acquiring an additional 650 shares during the last quarter. Victory Capital Management Inc. lifted its position in Teladoc Health by 4.3% during the third quarter. Victory Capital Management Inc. now owns 17,946 shares of the health services provider’s stock worth $334,000 after acquiring an additional 748 shares during the last quarter. Principal Financial Group Inc. lifted its position in Teladoc Health by 7.4% during the third quarter. Principal Financial Group Inc. now owns 12,774 shares of the health services provider’s stock worth $237,000 after acquiring an additional 883 shares during the last quarter. Sunbelt Securities Inc. lifted its position in Teladoc Health by 3.7% during the third quarter. Sunbelt Securities Inc. now owns 24,877 shares of the health services provider’s stock worth $462,000 after acquiring an additional 899 shares during the last quarter. Finally, Ignite Planners LLC lifted its position in Teladoc Health by 10.6% during the fourth quarter. Ignite Planners LLC now owns 12,450 shares of the health services provider’s stock worth $273,000 after acquiring an additional 1,190 shares during the last quarter. 76.82% of the stock is owned by institutional investors.

Insider Activity at Teladoc Health

In related news, insider Laizer Kornwasser sold 7,882 shares of the stock in a transaction on Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the transaction, the insider now owns 57,223 shares of the company’s stock, valued at approximately $1,097,537.14. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, COO Michael Willem Waters sold 4,523 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $86,751.14. Following the transaction, the chief operating officer now owns 38,570 shares in the company, valued at $739,772.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Laizer Kornwasser sold 7,882 shares of the business’s stock in a transaction dated Friday, February 2nd. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76. Following the transaction, the insider now owns 57,223 shares in the company, valued at approximately $1,097,537.14. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 135,441 shares of company stock valued at $2,038,251. Insiders own 1.63% of the company’s stock.

Teladoc Health Price Performance

TDOC stock opened at $13.01 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.47 and a current ratio of 3.54. Teladoc Health, Inc. has a 52 week low of $12.65 and a 52 week high of $30.41. The firm’s fifty day moving average is $15.01 and its 200 day moving average is $17.77. The firm has a market cap of $2.20 billion, a P/E ratio of -9.71 and a beta of 0.94.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.47% and a negative return on equity of 9.22%. The business had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same period in the prior year, the business posted ($0.37) EPS. Teladoc Health’s revenue for the quarter was up 2.7% on a year-over-year basis. Research analysts predict that Teladoc Health, Inc. will post -1.07 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on TDOC shares. Royal Bank of Canada dropped their price target on shares of Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday. SVB Leerink started coverage on shares of Teladoc Health in a research report on Monday, February 26th. They issued a “market perform” rating and a $17.00 price target for the company. Stifel Nicolaus dropped their price target on shares of Teladoc Health from $21.00 to $16.00 and set a “hold” rating for the company in a research report on Friday. Canaccord Genuity Group dropped their price target on shares of Teladoc Health from $28.00 to $25.00 and set a “buy” rating for the company in a research report on Friday. Finally, Oppenheimer dropped their price target on shares of Teladoc Health from $26.00 to $21.00 and set an “outperform” rating for the company in a research report on Friday. Eleven research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and a consensus target price of $19.67.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.